LMYC antibody (full length)
Quick Overview for LMYC antibody (full length) (ABIN7878881)
Target
See all LMYC (MYCL) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- full length
-
Purpose
- L-Myc Antibody / MYCL1
-
Purification
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human MYCL protein was used as the immunogen for the L-Myc antibody.
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- Optimal dilution of the L-Myc antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the L-Myc antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- LMYC (MYCL) (Protein L-Myc (MYCL))
-
Alternative Name
- L-Myc
-
Background
- Oncogene-encoded proteins c-Myc, N-Myc, and L-Myc function in cell proliferation, differentiation and neoplastic disease. Amplification of the c-Myc gene has been found in several types of human tumors, the N-Myc gene in neuroblastomas, and the L-Myc gene in human small cell lung carcinomas. c-Myc protein is a transcription factor localized to the nucleus of the cell. It seems to be involved in activating the transcription of growth-related genes. c-Myc binds to DNA during transcription as a heterodimeric complex with Max. c-Myc is phosphorylated in vitro by p44/42 MAP kinase at Ser62 and in vivo at both Thr58 and Ser62. Mutation of Thr58 and Ser62 to Ala inhibits the ability of c-Myc to activate transcription.
-
UniProt
- P12524
-
Pathways
- Warburg Effect
Target
-